Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt

Journal of Viral Hepatitis

Volumn 22, Issue 3, 2015, Pages 245-253

  Bonnard, P ^a,b   Elsharkawy, A ^c   Zalata, K ^d   Delarocque Astagneau, E ^e   Biard, L ^e   Le Fouler, L ^e   Hassan, A B ^c   Abdel Hamid, M ^f,g   El Daly, M ^g   Gamal, M E ^g   El Kassas, M ^g   Bedossa, P ^h   Carrat, F ^b   Fontanet, A ^e,i   Esmat, G ^g  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c CAIRO UNIVERSITY   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

^e INSTITUT PASTEUR   (France)

^f Minia University   (Egypt)

^g NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

^h BEAUJON HOSPITAL   (France)

ⁱ University of Paris Cité   (France)

Author keywords

Egypt; hepatic elastography; hepatitis C virus; liver biopsy; liver fibrosis; serum markers

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; CHORIONIC GONADOTROPIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; BIOPSY DEVICE; BODY MASS; CHILD PUGH SCORE; COMPARATIVE EFFECTIVENESS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EGYPT; ELASTOGRAPH; ELASTOGRAPHY; FEMALE; GOLD STANDARD; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER FUNCTION TEST KIT; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NON INVASIVE PROCEDURE; PORTAL VEIN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTHROMBIN TIME; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHISTOSOMIASIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; VALIDITY; BIOPSY; CHRONIC HEPATITIS C; COMPLICATION; GENETICS; GENOTYPE; HEPACIVIRUS; LIVER CIRRHOSIS; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; VIROLOGY;

ADULT; BIOPSY; EGYPT; ELASTICITY IMAGING TECHNIQUES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84923183732     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12285     Document Type: Article

References (31)

1. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24 (2): 289-293.
2. Ghany MG, Strader DB, Thomas DL, Seeff LB., Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49 (4): 1335-1374.
3. Strader DB, Wright T, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39 (4): 1147-1171.
4. Bravo AA, Sheth SG, Chopra S,. Liver biopsy. N Engl J Med 2001; 344 (7): 495-500.
5. West J, Card TR,. Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology 2010; 139 (4): 1230-1237.
6. Rousselet MC, et al,. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41 (2): 257-264.
7. Regev A, et al,. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97 (10): 2614-2618.
8. Mehta SH, Lau B, Afdhal NH, Thomas DL,. Exceeding the limits of liver histology markers. J Hepatol 2009; 50 (1): 36-41.
9. Castera L,. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009; 16 (5): 300-314.
10. Deuffic-Burban S, Mohamed SK, Larouze B, Carrat F, Valleron AJ,. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006; 44 (3): 455-461.
11. Breban R, et al,. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat 2013; 20 (4): 294-296.
12. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR,. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94 (9): 2467-2474.
13. Constantine NT, Abdel-Hamid M, Oldach D,. Rapid genotyping of hepatitis C virus. N Engl J Med 1995; 333 (12): 800.
14. McOmish F, et al,. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32 (4): 884-892.
15. Wai CT, et al,. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38 (2): 518-526.
16. Vallet-Pichard A, Mallet V, Pol S,. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. Hepatology, 2006; 44 (3): 769; author reply 769-770.
17. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T,. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357 (9262): 1069-1075.
18. Ziol M, et al,. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41 (1): 48-54.
19. Al-Hamoudi W, et al,. Treatment of genotype 4 hepatitis C recurring after liver transplantation using a combination of pegylated interferon alfa-2a and ribavirin. Dig Dis Sci 2011; 56 (6): 1848-1852.
20. Robin X, et al,. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
21. Poynard T, et al,. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate. Clin Res Hepatol Gastroenterol, 2011; 35 (11): 720-730.
22. Lambert J, Halfon P, Penaranda G, Bedossa P, Cacoub P, Carrat F,. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008; 54 (8): 1372-1378.
23. Carrat F,. Integrating the applicability rate into the performance evaluation of noninvasive staging of liver fibrosis: a step towards a change from the "accuracy" to the "clinical" paradigm. Clin Res Hepatol Gastroenterol 2011; 35 (11): 691-692.
24. Obuchowski NA, Goske MJ, Applegate KE,. Assessing physicians' accuracy in diagnosing paediatric patients with acute abdominal pain: measuring accuracy for multiple diseases. Stat Med 2001; 20 (21): 3261-3278.
25. Khattab MA, et al,. Management of hepatitis C virus genotype 4: recommendations of an international expert panel. J Hepatol 2011; 54 (6): 1250-1262.
26. Usluer G, et al,. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C. Eur J Clin Microbiol Infect Dis 2012; 31 (8): 1873-1878.
27. Castera L, et al,. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128 (2): 343-350.
28. Khairy M, et al,. Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup. Hepat Mon 2012; 12 (11): e6718.
29. Wong GL, et al,. Association between anthropometric parameters and measurements of liver stiffness by transient elastography. Clin Gastroenterol Hepatol, 2013; 11 (3): 295-302 e1-3.
30. Kamal SM, Nasser IA,. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 2008; 47 (4): 1371-1383.
31. Sebastiani G, Alberti A,. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12 (23): 3682-3694.